Association of Arginine Vasopressin Levels With Outcomes and the Effect of V2 Blockade in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction — David E. Lanfear (2012) | RDL Network
Association of Arginine Vasopressin Levels With Outcomes and the Effect of V2 Blockade in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
Article 2012 en
Authors
DL
David E. Lanfear
HS
Hani N. Sabbah
SG
Steven R. Goldsmith
Abstract
1 min read
Elevated baseline AVP level was independently predictive of mortality, but did not identify a group of patients who had improved outcomes with tolvaptan treatment. Tolvaptan treatment increased AVP levels during follow-up, but this incremental increase was not associated with worsened outcomes.
Stephen J. Greene, Faı̈ez Zannad, Gregg C. Fonarow, Haris Subačius, Marco Triggiani, Andrew P. Ambrosy, Michael Böhm, Javed Butler, Ovidiu Chioncel, Aldo Maggioni, Scott D. Solomon, Muthiah Vaduganathan, Mihai Gheorghiade, Michele Senni
Muthiah Vaduganathan, Baljash Cheema, Erin R. Cleveland, K. Nathan Sankar, Haris Subačius, Gregg C. Fonarow, Scott D. Solomon, Eldrin F. Lewis, Stephen J. Greene, Aldo Maggioni, Michael Böhm, Faı̈ez Zannad, Javed Butler, Mihai Gheorghiade
Stephen J. Greene, Javed Butler, Gregg C. Fonarow, Haris Subačius, Andrew P. Ambrosy, Muthiah Vaduganathan, Marco Triggiani, Scott D. Solomon, Eldrin F. Lewis, Aldo Maggioni, Michael Böhm, Ovidiu Chioncel, Savina Nodari, Michele Senni, Faı̈ez Zannad, Mihai Gheorghiade
Norman C. Wang, Jonathan P. Piccini, Marvin A. Konstam, Aldo Maggioni, Brian Traver, Karl Swedberg, James E. Udelson, Faı̈ez Zannad, Thomas D. Cook, Christopher M. O’Connor, Alan B. Miller, Liliana Grinfeld, Mihai Gheorghiade
Andrew P. Ambrosy, Muthiah Vaduganathan, Mark D. Huffman, Sadiya S. Khan, Mary Kwasny, Angela J. Fought, Aldo Maggioni, Karl Swedberg, Marvin A. Konstam, Faı̈ez Zannad, Mihai Gheorghiade
Discussion(0)
No comments yet. Be the first to comment.